bibliographic resource 2517970 [br/2517970]
https://w3id.org/oc/corpus/br/2517970

is a

• document
• article

title

• Randomized Phase III Trial of Temsirolimus Versus Sorafenib As Second-Line Therapy After Sunitinib in Patients With Metastatic Renal Cell Carcinoma

publication date

• 2013-01-01

contributor

• https://w3id.org/oc/corpus/ar/9204106
• https://w3id.org/oc/corpus/ar/9204107
• https://w3id.org/oc/corpus/ar/9204108
• https://w3id.org/oc/corpus/ar/9204109
• https://w3id.org/oc/corpus/ar/9204110
• https://w3id.org/oc/corpus/ar/9204111
• https://w3id.org/oc/corpus/ar/9204112
• https://w3id.org/oc/corpus/ar/9204113
• https://w3id.org/oc/corpus/ar/9204114
• https://w3id.org/oc/corpus/ar/9204115
• https://w3id.org/oc/corpus/ar/9204116
• https://w3id.org/oc/corpus/ar/9204117

format

• https://w3id.org/oc/corpus/re/1335008

identifier

• https://w3id.org/oc/corpus/id/16088777
• https://w3id.org/oc/corpus/id/4768817
• https://w3id.org/oc/corpus/id/4768818
• https://w3id.org/oc/corpus/id/4768819

part of

• https://w3id.org/oc/corpus/br/577544